 Connection
Robert Breeze to Neurologic Examination
This is a "connection" page, showing publications Robert Breeze has written about Neurologic Examination.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.026 |
|
|
|
-
Freed CR, Breeze RE, Rosenberg NL, Schneck SA. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals. Adv Neurol. 1993; 60:721-8.
Score: 0.007
-
Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med. 1992 Nov 26; 327(22):1549-55.
Score: 0.007
-
Litofsky NS, Zee CS, Breeze RE, Chandrasoma PT. Meningeal melanocytoma: diagnostic criteria for a rare lesion. Neurosurgery. 1992 Nov; 31(5):945-8.
Score: 0.007
-
Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Wells TH, Barrett JN, Grafton ST, Huang SC, Eidelberg D, Rottenberg DA. Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol. 1990 May; 47(5):505-12.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|